Bensen Daniel 4
4 · Tyra Biosciences, Inc. · Filed Jan 20, 2026
Insider Transaction Report
Form 4
Bensen Daniel
Chief Discovery Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-01-12$28.44/sh−6,983$198,610→ 155,998 total - Sale
Common Stock
[F1][F3]2026-01-12$29.08/sh−1,017$29,575→ 154,981 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $27.9083 to $28.84. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $28.9131 to $29.23. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact|2026-01-20